Abstract
Aim:
To characterize the pharmacokinetic and pharmacodynamic profiles of the recombinant human erythropoietin (rhEPO)-loaded poly(lactic-co-glycolic acid) (PLGA) microspheres in rats.
Methods:
The rhEPO-loaded microspheres were prepared using a solid-in-oil-in-water emulsion method. Pharmacokinetics and pharmacodynamics of the rhEPO-loaded microspheres were evaluated in male Sprague-Dawley rats. The serum rhEPO level was determined with ELISA. The level of anti-rhEPO antibody in the serum was measured to assess the immunogenicity of rhEPO released from the microspheres.
Results:
rhEPO was almost completely released from the PLGA microspheres in vitro, following zero-order release kinetics over approximately 30 d. After intramuscular injection (10 000 or 30 000 IU rhEPO/kg) in the rats, the serum rhEPO concentration reached maximum levels on d 1, then decreased gradually and was maintained at nearly steady levels for approximately 4 weeks. Furthermore, the release of rhEPO from the PLGA microspheres was found to be controlled mainly by a dissolution/diffusion mechanism. A good linear correlation (R2=0.98) was obtained between the in vitro and in vivo release data. A single intramuscular injection of the rhEPO-loaded PLGA microspheres (10 000 or 30 000 IU rhEPO/kg) in the rats resulted in elevated hemoglobin and red blood cell concentrations for more than 28 d. Moreover, the immunogenicity of rhEPO released from the PLGA microspheres was comparable with that of the unencapsulated rhEPO.
Conclusion:
The results prove the feasibility of using the PLGA-based microspheres to deliver rhEPO for approximately 1 month.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Davis JM, Aralkawas T, Strickland TW, Yphantis DA . Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 1987; 26: 2633–8.
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW . Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73–8.
Markham A, Bryson H, Epoetin A . A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in non-renal applications. Drugs 1995; 49: 232–54.
Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM . Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release 2008; 125: 193–209.
Pisal DS, Kosloski MP, Balu-Iyer SV . Delivery of therapeutic proteins. J Pharm Sci 2010; 99: 2557–75.
Morlock M, Koll H, Winter G, Kissel T . Microencapsulation of rh-erythropoietin, using biodegradable poly(DL,-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 1997; 43: 29–36.
Morlock M, Kissel T, Li YX, Koll H, Winter G . Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J Control Release 1998; 56: 105–15.
Pistel KF, Bittner B, Koll H, Winter G, Kissel T . Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: Influence of encapsulation technique and polymer composition on particle characteristics. J Control Release 1999; 59: 309–25.
Geng Y, Yuan W, Wu F, Chen J, He M, Jin T . Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein. J Control Release 2008; 130: 259–65.
Morita T, Horikiri Y, Yamahara H, Suzuki T, Yoshino H . Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly(ethylene glycol) aqueous mixture. Pharm Res 2000; 17: 1367–73.
Morita T, Sakamura Y, Horikiri Y, Suzuki T, Yoshino H . Protein encapsulation into biodegradable microspheres by a novel s/o/w emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J Control Release 2000; 69: 435–44.
Zhu G, Mallery SR, Schwendeman SP . Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat Biotechnol 2000; 18: 52–7.
El-Sayed YM, Niazy EM, Khidr SH . In vivo evaluation of sustained-release microspheres of metoclopramide hydrochloride in beagle dogs. Int J Pharm 1995; 123: 113–8.
He J, Feng M, Zhou X, Ma Sh, Jiang Y, Wang Y, et al. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm 2011; 416: 69–76.
Wischke C, Schwendeman SP . Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008; 364: 298–327.
Sun Y, Wang J, Zhang X, Zhang Z, Zheng Y, Chen D, et al. Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies. J Control Release 2008; 129: 192–9.
Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R . Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 1991; 8: 713–20.
Zolnik BS, Burgess DJ . Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 2008; 127: 137–45.
Chu DF, Fu XQ, Liu WH, Liu K, Li YX . Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm 2006; 325: 116–23.
Van Dijkhuizen-Radersma R, Wright SJ, Taylor LM, John BA, De Groot K, Bezemer JM . In vitro/in vivo correlation for 14C-methylated lysozyme release from poly(ether-ester) microspheres. Pharm Res 2004; 21: 484–91.
Tamber H, Johansen P, Merkle HP, Gander B . Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005; 57: 357–76.
Nagao M, Suga H, Okano M, Masuda S, Narita H, Ikura K, et al. Nucleotide sequence of rat erythropoietin. Biochim Biophys Acta 1992; 1171; 99–102.
Lee HJ, Riley G, Johnson O, Cleland JL, Kim N, Charnis M, et al. In vivo characterization of sustained-release formulations of human growth hormone. J Pharmacol Exp Ther 1997; 281: 1431–9.
Acknowledgements
This project was supported by the Provincial Science and Technology Department of Hebei Province (09276418D-3) and the Science and Technology Project of the Provincial Education Department of Hebei (200645).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, Xl., He, Jt., Du, Hj. et al. Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats. Acta Pharmacol Sin 33, 137–144 (2012). https://doi.org/10.1038/aps.2011.157
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.157
Keywords
This article is cited by
-
Experimental study on microstructure and mechanical properties of lacustrine shale under water-rock interaction
Arabian Journal of Geosciences (2022)
-
Mechanical Properties of Gas Shale During Drilling Operations
Rock Mechanics and Rock Engineering (2017)
